Indicates Matter Stricken

Indicates New Matter

 

Committee Report

March 21, 2024

 

H. 4082

 

Introduced by Rep. Bannister

 

S. Printed 03/21/24--H.

Read the first time March 07, 2023

 

________

 

The committee on House Ways and Means

To whom was referred a Bill (H. 4082) to amend the South Carolina Code of Laws by amending Section 12-36-2120, relating to sales tax exemptions so as to exempt certain medicine used for ophthalmic disease, etc., respectfully

Report:

That they have duly and carefully considered the same, and recommend that the same do pass with amendment:

 

    Amend the bill, as and if amended, SECTION 1, by striking Section 12-36-2120(g) and inserting:

    (g) insertable medicine used in the prevention, treatment, or cure of an ophthalmic disease or condition so long as the medicine is administered by or pursuant to the supervision of a physician, and in an office which is under the supervision of a physician, in an independent surgery center, or in a hospital-based outpatient department.  For purposes of this subitem, physician has the same meaning as provided in Section 40-47-20;

Amend the bill further, by striking SECTION 2 and inserting:

SECTION 2.  This act takes effect on July 1, 2024.

 

Renumber sections to conform.

Amend title to conform.

 

B.W. BANNISTER for Committee.

 

 

statement of estimated fiscal impact

Explanation of Fiscal Impact

State Expenditure

This bill exempts from sales tax, insertable medicine used in the prevention, treatment, or cure of an ophthalmic disease or condition. The medicine must be administered by or pursuant to the supervision of a physician, and in an office under the supervision of a physician, in an independent surgery center, or in a hospital-based outpatient department. This bill codifies existing Proviso 117.184, and therefore, the bill will have no impact on DOR to administer the exemption.

 

State Revenue

This bill will have no state revenue impact. The exempt sales outlined by this bill are already exempt under Proviso 117.184 of the FY 2023-24 Appropriations Act, and therefore, are already considered in the BEA General Fund revenue estimate.

 

 

Frank A. Rainwater, Executive Director

Revenue and Fiscal Affairs Office

 

________

 

 

 

 

 

 

 

 

 

A bill

 

TO AMEND THE SOUTH CAROLINA CODE OF LAWS BY AMENDING SECTION 12-36-2120, RELATING TO SALES TAX EXEMPTIONS SO AS TO EXEMPT CERTAIN MEDICINE USED FOR OPHTHALMIC DISEASE.

 

Be it enacted by the General Assembly of the State of South Carolina:

 

SECTION 1.  Section 12-36-2120(28) of the S.C. Code is amended by adding a subitem to read:

 

    (g) insertable medicine used in the prevention, treatment, or cure of an ophthalmic disease or condition so long as the medicine is administered by or pursuant to the supervision of a physician, and in an office which is under the supervision of a physician, in an independent surgery center, or in a hospital-based outpatient department;

 

SECTION 2.  This act takes effect on July 1, 2023.

----XX----